Quick Answer
Neurogene Inc. reported Earnings Per Share Diluted of $4.24 (loss) per share for the year ending 2025.
- Neurogene Inc. showed an increase of +0.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Neurogene Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2017: $0.59 (loss) per share | Q2 2018: $0.12 per share | Q1 2020: $0.18 (loss) per share | Q2 2020: $0.20 (loss) per share | Q3 2020: $0.04 (loss) per share | Q1 2021: $0.27 (loss) per share | Q2 2021: $0.27 (loss) per share | Q3 2021: $0.28 (loss) per share | Q1 2022: $0.28 (loss) per share | Q2 2022: $0.28 (loss) per share | Q3 2022: $1.18 (loss) per share | Q1 2023: $0.26 (loss) per share | Q2 2023: $26.68 (loss) per share | Q3 2023: $32.67 (loss) per share | Q1 2024: $1.00 (loss) per share | Q2 2024: $1.09 (loss) per share | Q3 2024: $1.19 (loss) per share | Q1 2025: $1.08 (loss) per share | Q2 2025: $1.05 (loss) per share | Q3 2025: $0.99 (loss) per share.
- Over the full 6 years of available data (2020 to 2025), Neurogene Inc.'s Earnings Per Share Diluted has declined by 562.5%.
- Historical annual values: Fiscal year 2025: $4.24 (loss) per share | Fiscal year 2024: $4.28 (loss) per share | Fiscal year 2023: $2.93 per share | Fiscal year 2022: $1.04 (loss) per share | Fiscal year 2021: $1.10 (loss) per share | Fiscal year 2020: $0.64 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: